Chronic Lung Disease Clinical Trial
Official title:
A Supraglottic Instillation Device for Administration of Surfactant in Neonates- A Pilot Study
A pilot study to explore and determine feasibility and safety of the administration of surfactant through a new supraglottic device in patients from 500 to 5000 grams with RDS.
Surfactant therapy can be life-saving for newborn infants with respiratory distress due to surfactant insufficiency, also known as respiratory distress syndrome (RDS). All commercially available surfactants for clinical use are approved for administration through an endotracheal tube. Placement of an endotracheal tube, a procedure called intubation, is stressful for the infant and associated with significant adverse effects. The proposed supraglottic instillation device allows infants to benefit from surfactant therapy while avoiding the negative effects of intubation. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Completed |
NCT00783978 -
Surfactant Disorders and Chronic Lung Disease
|
N/A | |
Not yet recruiting |
NCT05025774 -
Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise
|
||
Completed |
NCT04663685 -
MoveStrong at Home: A Feasibility Study of a Model for Remote Delivery of Functional Strength and Balance Training Combined With Nutrition Education for Older Pre-frail Adults.
|
N/A | |
Recruiting |
NCT06112730 -
Nutritional Supplementation in Patients With Chronic Respiratory Disease
|
N/A | |
Not yet recruiting |
NCT03180164 -
Depression in Chronic Airways Diseases
|
N/A | |
Completed |
NCT02544984 -
The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung Disease
|
N/A | |
Recruiting |
NCT01721655 -
Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
|
Phase 2/Phase 3 | |
Completed |
NCT00233064 -
Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)
|
Phase 4 | |
Recruiting |
NCT05866302 -
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
|
||
Not yet recruiting |
NCT06326957 -
Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention (SELF-BREATHE)
|
N/A | |
Completed |
NCT01326611 -
Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants
|
Phase 4 | |
Completed |
NCT05776264 -
Exercise Strategies to Motivate and Relieve Stress
|
N/A | |
Completed |
NCT03773991 -
Dyspnea Assessment in Hemodialysis Patients
|
||
Completed |
NCT02055339 -
Pilot Study Comparing Different Modes of Non-invasive Ventilation for the Oral Feeding of Preterm Infants
|
N/A | |
Withdrawn |
NCT03673566 -
Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - CHMCO
|
N/A | |
Completed |
NCT02426112 -
Bronchopulmonary Function in Response to Azithromycin Treatment for Chronic Lung Disease in HIV-infected Children
|
Phase 3 | |
Recruiting |
NCT00710112 -
Genetic Variants and Susceptibility to Diseases of Prematurity in Very Low Birth-Weight Infants
|
||
Withdrawn |
NCT03673579 -
Clinical Evaluation of the "NICU Clinical Decision Support Dashboard" - MHSB
|
N/A | |
Active, not recruiting |
NCT03018717 -
Integral Clinical Plan Shared With or Without Telemonitoring of Constants in Patient With Chronic Diseases
|
N/A |